BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ren ZH, Zhang CP, Ji T. Expression of SOX2 in oral squamous cell carcinoma and the association with lymph node metastasis. Oncol Lett 2016;11:1973-9. [PMID: 26998109 DOI: 10.3892/ol.2016.4207] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 de Vicente JC, Donate-Pérez Del Molino P, Rodrigo JP, Allonca E, Hermida-Prado F, Granda-Díaz R, Rodríguez Santamarta T, García-Pedrero JM. SOX2 Expression Is an Independent Predictor of Oral Cancer Progression. J Clin Med 2019;8:E1744. [PMID: 31640140 DOI: 10.3390/jcm8101744] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
2 Hu Z, Yang R, Li L, Mao L, Liu S, Qiao S, Ren G, Hu J. Validation of Gene Profiles for Analysis of Regional Lymphatic Metastases in Head and Neck Squamous Cell Carcinoma. Front Mol Biosci 2020;7:3. [PMID: 32118031 DOI: 10.3389/fmolb.2020.00003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Bourguignon LYW, Earle C, Shiina M. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells. Int J Mol Sci 2017;18:E1849. [PMID: 28837080 DOI: 10.3390/ijms18091849] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
4 Lonardi S, Missale F, Calza S, Bugatti M, Vescovi R, Debora B, Uppaluri R, Egloff AM, Mattavelli D, Lombardi D, Benerini Gatta L, Marini O, Tamassia N, Gardiman E, Cassatella MA, Scapini P, Nicolai P, Vermi W. Tumor-associated neutrophils (TANs) in human carcinoma-draining lymph nodes: a novel TAN compartment. Clin Transl Immunology 2021;10:e1252. [PMID: 33643653 DOI: 10.1002/cti2.1252] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Dasgupta S, Koljenović S, van den Bosch TPP, Swagemakers SMA, van der Hoeven NMA, van Marion R, van der Spek PJ, van Doorn HC, van Kemenade FJ, Ewing-Graham PC. Evaluation of Immunohistochemical Markers, CK17 and SOX2, as Adjuncts to p53 for the Diagnosis of Differentiated Vulvar Intraepithelial Neoplasia (dVIN). Pharmaceuticals (Basel) 2021;14:324. [PMID: 33918187 DOI: 10.3390/ph14040324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ren ZH, Lin CZ, Cao W, Yang R, Lu W, Liu ZQ, Chen YM, Yang X, Tian Z, Wang LZ, Li J, Wang X, Chen WT, Ji T, Zhang CP. CD73 is associated with poor prognosis in HNSCC. Oncotarget 2016;7:61690-702. [PMID: 27557512 DOI: 10.18632/oncotarget.11435] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
7 Ghazi N, Aali N, Shahrokhi VR, Mohajertehran F, Saghravanian N. Relative Expression of SOX2 and OCT4 in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia. Rep Biochem Mol Biol 2020;9:171-9. [PMID: 33178866 DOI: 10.29252/rbmb.9.2.171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Feng X, Lu M. Expression of sex-determining region Y-box protein 2 in breast cancer and its clinical significance. Saudi Med J 2017;38:685-90. [PMID: 28674712 DOI: 10.15537/smj.2017.7.19372] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
9 Hassn Mesrati M, Behrooz AB, Y Abuhamad A, Syahir A. Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer. Cells 2020;9:E1236. [PMID: 32429463 DOI: 10.3390/cells9051236] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
10 Hamilton KL, Sheehan SA, Retzbach EP, Timmerman CA, Gianneschi GB, Tempera PJ, Balachandran P, Goldberg GS. Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways. J Cancer Res Clin Oncol 2021;147:445-57. [PMID: 33205348 DOI: 10.1007/s00432-020-03456-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Tahmasebi E, Alikhani M, Yazdanian A, Yazdanian M, Tebyanian H, Seifalian A. The current markers of cancer stem cell in oral cancers. Life Sci 2020;249:117483. [PMID: 32135187 DOI: 10.1016/j.lfs.2020.117483] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Júnior JF, de França GM, da Silva Barros CC, Felix FA, da Silva WR, de Lucena HF, Oliveira CN, Galvão HC. Biomarkers involved in the proliferation of the odontogenic keratocyst, glandular odontogenic cyst and botryoid odontogenic cyst. Oral Maxillofac Surg. [DOI: 10.1007/s10006-021-01026-x] [Reference Citation Analysis]
13 Li Q, Aishwarya S, Li J, Pan D, Shi J. Gene Expression Profiling of Glioblastoma to Recognize Potential Biomarker Candidates. Front Genet 2022;13:832742. [DOI: 10.3389/fgene.2022.832742] [Reference Citation Analysis]
14 Luiz ST, Modolo F, Mozzer I, dos Santos EC, Nagashima S, Camargo Martins AP, de Azevedo MLV, Azevedo Alanis LR, Hardy AMTG, de Moraes RS, Aguiar MCF, Ignácio SA, Jham BC, Noronha L, Johann ACBR. Immunoexpression of SOX-2 in oral leukoplakia. Oral Dis 2018;24:1449-57. [DOI: 10.1111/odi.12922] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
15 Wolmarans E, Boy SC, Nel S, Mercier AE, Pepper MS. Cancer Stem Cells in Head and Neck Carcinomas: Identification and Possible Therapeutic Implications. Adv Exp Med Biol 2018;1083:89-102. [PMID: 29139089 DOI: 10.1007/5584_2017_116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Wang H, Zhou Y, Liu Q, Xu J, Ma Y. Prognostic value of SOX2, Cyclin D1, P53, and ki-67 in patients with esophageal squamous cell carcinoma. Onco Targets Ther 2018;11:5171-81. [PMID: 30210237 DOI: 10.2147/OTT.S160066] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
17 Su CL, Tantoh DM, Chou YH, Wang L, Ho CC, Chen PH, Lee KJ, Nfor ON, Hsu SY, Liang WM, Liaw YP. Blood-Based SOX2-Promoter Methylation in Relation to Exercise and PM2.5 Exposure among Taiwanese Adults. Cancers (Basel) 2020;12:E504. [PMID: 32098209 DOI: 10.3390/cancers12020504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Zhang F, Wang J, Ma M, Xu Y, Lu X, Wei S. Genomic alteration profiles of lung cancer and their relationship to clinical features and prognosis value using individualized genetic testing. J Thorac Dis 2021;13:5007-15. [PMID: 34527339 DOI: 10.21037/jtd-21-1031] [Reference Citation Analysis]
19 Chung JH, Jung HR, Jung AR, Lee YC, Kong M, Lee JS, Eun YG. SOX2 activation predicts prognosis in patients with head and neck squamous cell carcinoma. Sci Rep 2018;8:1677. [PMID: 29374236 DOI: 10.1038/s41598-018-20086-w] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
20 Sasahira T, Nishiguchi Y, Kurihara-Shimomura M, Nakashima C, Kuniyasu H, Kirita T. NIPA-like domain containing 1 is a novel tumor-promoting factor in oral squamous cell carcinoma. J Cancer Res Clin Oncol 2018;144:875-82. [PMID: 29464350 DOI: 10.1007/s00432-018-2612-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
21 Mao Y, Zhang W, Zhang R, Zuo J. Alkannin restrains oral squamous carcinoma cell growth, migration and invasion by regulating microRNA-9/RECK axis. Artificial Cells, Nanomedicine, and Biotechnology 2019;47:3153-62. [DOI: 10.1080/21691401.2019.1642206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Regiart M, Gimenez AM, Lopes AT, Carreño MNP, Bertotti M. Ultrasensitive microfluidic electrochemical immunosensor based on electrodeposited nanoporous gold for SOX-2 determination. Anal Chim Acta 2020;1127:122-30. [PMID: 32800115 DOI: 10.1016/j.aca.2020.06.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Suárez-Sánchez FJ, Lequerica-Fernández P, Rodrigo JP, Hermida-Prado F, Suárez-Canto J, Rodríguez-Santamarta T, Domínguez-Iglesias F, García-Pedrero JM, de Vicente JC. Tumor-Infiltrating CD20+ B Lymphocytes: Significance and Prognostic Implications in Oral Cancer Microenvironment. Cancers (Basel) 2021;13:395. [PMID: 33494389 DOI: 10.3390/cancers13030395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Zhang L, Guo C, Ji T, Chen X. SOX2 Regulates lncRNA CCAT1/MicroRNA-185-3p/FOXP3 Axis to Affect the Proliferation and Self-Renewal of Cervical Cancer Stem Cells. Nanoscale Res Lett 2021;16:2. [PMID: 33394184 DOI: 10.1186/s11671-020-03449-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Baghai Naini F, Aminishakib P, Abdollahi A, Hodjat M, Mohammadpour H, Kardouni Khoozestani N. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue. Asian Pac J Cancer Prev 2019;20:1649-54. [PMID: 31244283 DOI: 10.31557/APJCP.2019.20.6.1649] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
26 Li Y, Lin H, Deng N, Xie L, Luo R. Matrine from Vietnamese sophora root inhibits the growth of oral squamous cell carcinoma cells in vitro and in vivo. Food Sci Technol 2019;39:855-8. [DOI: 10.1590/fst.11518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Vipparthi K, Patel AK, Ghosh S, Das S, Das C, Das K, Sarkar A, Thatikonda V, Pal B, Remani ASKN, Arora N, Parihar M, Vijayakumar MV, Bhat MK, Boppana R, Bhattacharjee S, Biswas NK, Arun P, Sharan R, Singh S. Two novel cell culture models of buccal mucosal oral cancer from patients with no risk-habits of tobacco smoking or chewing. Oral Oncol 2021;113:105131. [PMID: 33387705 DOI: 10.1016/j.oraloncology.2020.105131] [Reference Citation Analysis]